Bangalore

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation. Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Covance Drug Development segment and Sciformix have completed the previously announced transactions that will strengthen and enhance the way our respective businesses support the life sciences industry. Sciformix’s brand recognition and leadership in the pharmacovigilance industry greatly expands Covance’s global pharmacovigilance footprint and offerings, already strengthened through the previous acquisition of Chiltern, with end-to-end PV services and supporting technologies, additional locations and resources. This exciting combination creates an organization with significant global scale and a full suite of PV capabilities across the entire product lifecycle from early stage development through commercialization.

National Institute of Mental Health and Neuro Sciences is a multidisciplinary Institute for patient care and academic pursuit in the frontier area of Mental Health and Neuro Sciences. The Lunatic Asylum which came into being in the latter part of the 19th Century was renamed as Mental Hospital in 1925 by the erstwhile Government of Mysore.

Applications are invited from eligible candidates, for the post of post of “Senior Research Fellow” (SRF) on contract basis for the ICMR funded project entitled “Cell-free therapeutic approach to Parkinson’s disease using exosomes of human dental pulp stem cells as drug delivery tool through intranasal route” – under the guidance of Dr. Indrani Datta, Associate Professor of Biophysics & Principal Investigator.

Post : Senior Research Fellow

The mass spectrometry facility is a core facility for scientists of the Bangalore Life Sciences Cluster (BLiSc) that includes inStem and the National Centre for Biological Science (NCBS) and the Centre for Cellular and Molecular Platforms which share a campus and research facilities. The facility comprises laboratories situated within the BLiSc campus. It provides services and training to a range of users. This position involves management and coordination of operations of the mass spectrometry facility. The head of the facility is expected to lead a team of staff whose work includes the maintenance of a facility with several state-of-the-art mass spectrometers and associated equipment. The role requires providing technical input into user projects, managing staff and work flow as well as the development and implementation of research grade experimental techniques using mass spectrometry. Training programs and outreach activities are encouraged.

Post : Fellow E (Scientist ‘D’) – Incharge, Mass Spectrometry (M S) Facility

Covance is one of the world’s largest and most comprehensive drug development services companies with more than 11,000 employees in 60 countries. Through its nonclinical, clinical and commercialization services, Covance has helped pharmaceutical and biotech companies develop one-third of all prescription medicines in the market today.

Post : Mgr Drug Safety

Quintiles and IMS Health have come together to become IQVIA, The Human Data Science Company. Inspired by the industry we help, IQVIA commits to providing solutions that enable life sciences companies to innovate with confidence, maximize their opportunities and ultimately drive human health outcomes forward.

Post : Patent Intelligence (External Consultant)

Founded by Dr. Muhammed Majeed, an internationally acclaimed scientist and entrepreneur in the area of "Alternative Medicine", Sami Labs Limited is a research-oriented multinational health science company and a leading producer of nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals, and probiotics. The Government of India honored Sami Labs Limited with the National Award for Quality Products (Basic Drugs) in the year 1994 and the Prestigious DSIR award in the year 2002. The company is endowed with independent research divisions including Natural drugs, Phytochemistry, Synthetic Chemistry, Tissue Culture, Biotechnology, Analytical R&D, Biological Research, Microbiology, and Formulations R&D, all of which coordinate in a synergistic work model to create products meeting international standards.

Post : Junior Scientist/Scientist